Australian Clinical Labs Future Growth

How is Australian Clinical Labs forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

-53.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

ASX:ACL - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2025	721	47	N/A	163	5
6/30/2024	696	44	144	153	6
6/30/2023	714	50	146	163	6
6/30/2022	996	178	263	284	N/A
3/31/2022	931	156	238	256	N/A
12/31/2021	867	134	214	228	N/A
9/30/2021	757	97	179	191	N/A
6/30/2021	647	60	144	154	N/A
3/31/2021	598	79	N/A	N/A	N/A
12/31/2020	549	98	N/A	N/A	N/A
9/30/2020	520	70	N/A	N/A	N/A
6/30/2020	491	41	92	102	N/A
6/30/2019	448	-11	-13	1	N/A
6/30/2018	379	-9	-4	5	N/A
6/30/2017	340	-24	-3	5	N/A

Earnings vs Savings Rate: ACL's earnings are forecast to decline over the next 3 years (-53.3% per year).

Earnings vs Market: ACL's earnings are forecast to decline over the next 3 years (-53.3% per year).

High Growth Earnings: ACL's earnings are forecast to decline over the next 3 years.

Revenue vs Market: ACL's revenue is expected to decline over the next 3 years (-6.6% per year).

High Growth Revenue: ACL's revenue is forecast to decline over the next 3 years (-6.6% per year).

Future ROE: ACL's Return on Equity is forecast to be low in 3 years time (18.9%).